QuantLogix

REGN vs VRTX — live signal comparison

Head-to-head on QuantLogix's 5-factor quant engine, recomputed throughout the trading day. An engine-read comparison — not a recommendation.

engine lead
REGN
Regeneron Pharmaceuticals, Inc. Common Stock
67/100
BUY
$807.67 · +0.33% · $80.8B
66% of similar setups up in 5d
Full scorecard →
VS
VRTX
Vertex Pharmaceuticals Incorporated Common Stock
60/100
BUY
$517.49 · -1.23% · $128.8B
58% of similar setups up in 5d
Full scorecard →
Factor by factor — REGN (left) vs VRTX (right)
64
Technical
64
60
Momentum
53
65
Fundamental
63
34
Options
49
73
Microstructure
60

QuantLogix's 5-factor engine currently reads Regeneron Pharmaceuticals, Inc. Common Stock (REGN) at 67/100 (buy) and Vertex Pharmaceuticals Incorporated Common Stock (VRTX) at 60/100 (buy). REGN carries the stronger composite read by 7 points, led by microstructure at 73/100. VRTX's strongest leg is technical at 64/100. In pattern backtesting, 66% of 50 REGN setups and 58% of 50 VRTX setups rose within five trading days. Signals recompute throughout the trading day — the balance can shift with the tape.

Track REGN with free signal alerts Browse all scorecards
🤖 Want the deeper take? Pro runs a 10-agent AI debate on either name — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. REGN scorecard · VRTX scorecard · REGN earnings · VRTX earnings · Today's movers · Verified track record